These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9329315)

  • 1. Intensive insulin treatment after acute myocardial infarction in diabetes mellitus. Intensive insulin regimens in primary prevention should be assessed.
    McLaughlin K
    BMJ; 1997 Aug; 315(7107):544-5. PubMed ID: 9329315
    [No Abstract]   [Full Text] [Related]  

  • 2. Intensive insulin treatment after acute myocardial infarction in diabetes mellitus. Factors other than continued use of subcutaneous insulin may be important.
    Fisher BM
    BMJ; 1997 Aug; 315(7107):544. PubMed ID: 9329314
    [No Abstract]   [Full Text] [Related]  

  • 3. Intensive insulin treatment after acute myocardial infarction in diabetes mellitus. Evidence exists from study of non-insulin dependent diabetes in Japan.
    Williams R
    BMJ; 1997 Aug; 315(7107):544. PubMed ID: 9329313
    [No Abstract]   [Full Text] [Related]  

  • 4. [Insulin in the diabetic heart patient, only the glycemic results count].
    Fredenrich A
    Soins; 2006 Mar; (703 Suppl 1):1S18-20. PubMed ID: 16604812
    [No Abstract]   [Full Text] [Related]  

  • 5. Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials.
    Pittas AG; Siegel RD; Lau J
    Arch Intern Med; 2004 Oct; 164(18):2005-11. PubMed ID: 15477435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen. The TRACE Study Group.
    Gustafsson I; Hildebrandt P; Seibaek M; Melchior T; Torp-Pedersen C; Køber L; Kaiser-Nielsen P
    Eur Heart J; 2000 Dec; 21(23):1937-43. PubMed ID: 11071799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive insulin treatment of diabetic patients with myocardial infarction is highly cost-effective.
    Hildebrandt P
    Eur Heart J; 2000 May; 21(9):700-2. PubMed ID: 10739721
    [No Abstract]   [Full Text] [Related]  

  • 8. The benefits of insulin therapy following acute myocardial infarction revisited.
    Soran H; Barzangy B; Younis N
    QJM; 2006 Sep; 99(9):635-7. PubMed ID: 16921196
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
    Meier JJ; Deifuss S; Klamann A; Schmiegel W; Nauck MA;
    Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):344-50. PubMed ID: 14520601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of intense insulin treatment after acute myocardial infarction in patients with diabetes mellitus; results from the DIGAMI study.
    Almbrand B; Johannesson M; Sjöstrand B; Malmberg K; Rydén L
    Eur Heart J; 2000 May; 21(9):733-9. PubMed ID: 10739728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolic control by means of insulin in patients with type 2 diabetes and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity--secondary publication].
    Gustafsson I; Malmberg K; Rydén L; Wedel H; Birkeland K; Bootsma A; Dickstein K; Efendic S; Fisher M; Hamsten A; Herlitz J; Hildebrandt PR; MacLeod K; Laakso M; Torp-Pedersen CT; Waldenström A;
    Ugeskr Laeger; 2006 Feb; 168(6):581-4. PubMed ID: 16476220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival after myocardial infarction in diabetic patients. Part II. Hospital mortality in relation to the kind of hypoglycaemic treatment.
    Królewski AS; Janeczko D; Kobryń A; Puncewicz B
    Acta Med Pol; 1975; 16(1):53-9. PubMed ID: 1119327
    [No Abstract]   [Full Text] [Related]  

  • 13. [Impact of intensive blood glucose control with hypoglycemic sulfamides, metformin or insulin on complications of non-insulin dependent diabetes].
    André P
    Rev Epidemiol Sante Publique; 1999 Mar; 47(1):93-5. PubMed ID: 10214683
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hyperglycemia in intensive care unit: what treatment for hyperglycemia during myocardial infarct in the diabetic patient?].
    Grimaldi A; Hartemann-Heurtier A
    Journ Annu Diabetol Hotel Dieu; 2003; ():195-216. PubMed ID: 12868310
    [No Abstract]   [Full Text] [Related]  

  • 15. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
    Aguilar D; Solomon SD; Køber L; Rouleau JL; Skali H; McMurray JJ; Francis GS; Henis M; O'Connor CM; Diaz R; Belenkov YN; Varshavsky S; Leimberger JD; Velazquez EJ; Califf RM; Pfeffer MA
    Circulation; 2004 Sep; 110(12):1572-8. PubMed ID: 15364810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of insulin-glucose infusion on mortality following acute myocardial infarction in patients with diabetes: the diabetes and insulin-glucose infusion in acute myocardial infarction studies.
    Malmberg K; Rydén L
    Semin Thorac Cardiovasc Surg; 2006; 18(4):326-9. PubMed ID: 17395029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intensive insulin therapy: results after ten years].
    Laube H
    Pharm Unserer Zeit; 2001 Jan; 30(1):40-5. PubMed ID: 11233182
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment after acute MI in diabetics.
    Hoekzema GS
    J Fam Pract; 1997 Sep; 45(3):201-2. PubMed ID: 9312560
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic strategies to improve the outcome of patients with diabetes mellitus and acute coronary syndrome].
    Cavallini C
    G Ital Cardiol (Rome); 2006 Apr; 7(4 Suppl 1):13S-20S. PubMed ID: 16749287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38.
    Wiviott SD; Braunwald E; Angiolillo DJ; Meisel S; Dalby AJ; Verheugt FW; Goodman SG; Corbalan R; Purdy DA; Murphy SA; McCabe CH; Antman EM;
    Circulation; 2008 Oct; 118(16):1626-36. PubMed ID: 18757948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.